» Articles » PMID: 38069347

Micronutrient Deficiency in Inherited Metabolic Disorders Requiring Diet Regimen: A Brief Critical Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Dec 9
PMID 38069347
Authors
Affiliations
Soon will be listed here.
Abstract

Many inherited metabolic disorders (IMDs), including disorders of amino acid, fatty acid, and carbohydrate metabolism, are treated with a dietary reduction or exclusion of certain macronutrients, putting one at risk of a reduced intake of micronutrients. In this review, we aim to provide available evidence on the most common micronutrient deficits related to specific dietary approaches and on the management of their deficiency, in the meanwhile discussing the main critical points of each nutritional supplementation. The emerging concepts are that a great heterogeneity in clinical practice exists, as well as no univocal evidence on the most common micronutrient abnormalities. In phenylketonuria, for example, micronutrients are recommended to be supplemented through protein substitutes; however, not all formulas are equally supplemented and some of them are not added with micronutrients. Data on pyridoxine and riboflavin status in these patients are particularly scarce. In long-chain fatty acid oxidation disorders, no specific recommendations on micronutrient supplementation are available. Regarding carbohydrate metabolism disorders, the difficult-to-ascertain sugar content in supplementation formulas is still a matter of concern. A ketogenic diet may predispose one to both oligoelement deficits and their overload, and therefore deserves specific formulations. In conclusion, our overview points out the lack of unanimous approaches to micronutrient deficiencies, the need for specific formulations for IMDs, and the necessity of high-quality studies, particularly for some under-investigated deficits.

Citing Articles

Current Insights into Nutritional Management of Phenylketonuria: An Update for Children and Adolescents.

Anton-Paduraru D, Trofin F, Chis A, Sur L, Streanga V, Mindru D Children (Basel). 2025; 12(2).

PMID: 40003301 PMC: 11854529. DOI: 10.3390/children12020199.


Mapping the evolution and impact of ketogenic diet research on diabetes management: a comprehensive bibliometric analysis from 2005 to 2024.

Li Z, Li A, Liu P, Zhang B, Yan Y Front Nutr. 2024; 11:1485642.

PMID: 39483785 PMC: 11527367. DOI: 10.3389/fnut.2024.1485642.

References
1.
Balasubramaniam S, Christodoulou J, Rahman S . Disorders of riboflavin metabolism. J Inherit Metab Dis. 2019; 42(4):608-619. DOI: 10.1002/jimd.12058. View

2.
Pinar-Sueiro S, Martinez-Fernandez R, Lage-Medina S, Aldamiz-Echevarria L, Vecino E . Optic neuropathy in methylmalonic acidemia: the role of neuroprotection. J Inherit Metab Dis. 2010; 33 Suppl 3:S199-203. DOI: 10.1007/s10545-010-9084-8. View

3.
Merritt 2nd J, Norris M, Kanungo S . Fatty acid oxidation disorders. Ann Transl Med. 2019; 6(24):473. PMC: 6331364. DOI: 10.21037/atm.2018.10.57. View

4.
Tolomeo M, Nisco A, Leone P, Barile M . Development of Novel Experimental Models to Study Flavoproteome Alterations in Human Neuromuscular Diseases: The Effect of Rf Therapy. Int J Mol Sci. 2020; 21(15). PMC: 7432027. DOI: 10.3390/ijms21155310. View

5.
Demirdas S, van Spronsen F, Hollak C, van der Lee J, Bisschop P, Vaz F . Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria. Ann Nutr Metab. 2017; 70(2):111-121. PMC: 5516403. DOI: 10.1159/000465529. View